Porcine reproductive and respiratory syndrome virus (PRRSv) modified-live vaccine reduces virus transmission in experimental conditions

scientific article published on 26 March 2015

Porcine reproductive and respiratory syndrome virus (PRRSv) modified-live vaccine reduces virus transmission in experimental conditions is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.VACCINE.2015.03.040
P698PubMed publication ID25820061

P2093author name stringN Rose
M Andraud
O Bourry
P Renson
F Paboeuf
M F Le Potier
P2860cites workInfectiousness of pigs infected by the Porcine Reproductive and Respiratory Syndrome virus (PRRSV) is time-dependentQ36397345
Assessment of the economic impact of porcine reproductive and respiratory syndrome on swine production in the United StatesQ40394450
Vaccination with a genotype 1 modified live vaccine against porcine reproductive and respiratory syndrome virus significantly reduces viremia, viral shedding and transmission of the virus in a quasi-natural experimental modelQ41640514
Results of a control programme for the porcine reproductive and respiratory syndrome in the French 'Pays de la Loire' regionQ43331767
Infectious agents associated with respiratory diseases in 125 farrow-to-finish pig herds: a cross-sectional studyQ44691563
Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity.Q45384517
Introduction, persistence and fade-out of porcine reproductive and respiratory syndrome virus in a Dutch breeding herd: a mathematical analysisQ45743752
Experimental quantification of vaccine-induced reduction in virus transmissionQ45780125
Design and analysis of small-scale transmission experiments with animalsQ47581066
Risk factors for porcine post-weaning multisystemic wasting syndrome (PMWS) in 149 French farrow-to-finish herdsQ51649252
Quantification of transmission in one-to-one experiments.Q51717662
Design and analysis of an Actinobacillus pleuropneumoniae transmission experimentQ73755756
A quantitative assessment of the effectiveness of PRRSV vaccination in pigs under experimental conditionsQ73980707
P433issue21
P407language of work or nameEnglishQ1860
P921main subjectporcine reproductive and respiratory syndrome virusQ1760147
porcine reproductive and respiratory syndromeQ2275037
viral transmissionQ123924092
P304page(s)2493-2499
P577publication date2015-03-26
P1433published inVaccineQ7907941
P1476titlePorcine reproductive and respiratory syndrome virus (PRRSv) modified-live vaccine reduces virus transmission in experimental conditions
P478volume33

Reverse relations

cites work (P2860)
Q93048878A DNA Prime Immuno-Potentiates a Modified Live Vaccine against the Porcine Reproductive and Respiratory Syndrome Virus but Does Not Improve Heterologous Protection
Q64059321A Field Recombinant Strain Derived from Two Type 1 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV-1) Modified Live Vaccines Shows Increased Viremia and Transmission in SPF Pigs
Q40099817A Multiplex RT-PCR Assay to Detect and Discriminate Porcine Reproductive and Respiratory Syndrome Viruses in Clinical Specimens
Q39673041A commercial PCV2a-based vaccine significantly reduces PCV2b transmission in experimental conditions.
Q92081675Assessment of pulmonary tissue responses in pigs challenged with PRRSV Lena strain shows better protection after immunization with field than vaccine strains
Q57092513Better horizontal transmission of a US non-InDel strain compared with a French InDel strain of porcine epidemic diarrhoea virus
Q57811799Bottlenecks in the transmission of porcine reproductive and respiratory syndrome virus (PRRSV1) to naïve pigs and the quasi-species variation of the virus during infection in vaccinated pigs
Q37668276Dynamic changes in bronchoalveolar macrophages and cytokines during infection of pigs with a highly or low pathogenic genotype 1 PRRSV strain
Q45323989Efficacy and safety of simultaneous vaccination with two modified live virus vaccines against porcine reproductive and respiratory syndrome virus types 1 and 2 in pigs
Q50045685Estimating Parameters Related to the Lifespan of Passively Transferred and Vaccine-Induced Porcine Reproductive and Respiratory Syndrome Virus Type I Antibodies by Modeling Field Data
Q36201071Evaluation of Control Strategies for Porcine Reproductive and Respiratory Syndrome (PRRS) in Swine Breeding Herds Using a Discrete Event Agent-Based Model
Q91776607Improving the management procedures in farms infected with the Porcine Reproductive and Respiratory Syndrome virus using PDP models
Q40085086In vitro and in vivo studies of deglycosylated chimeric porcine reproductive and respiratory syndrome virus as a vaccine candidate and its realistic revenue impact at commercial pig production level
Q34483700Live porcine reproductive and respiratory syndrome virus vaccines: Current status and future direction
Q40621020Maternally-derived antibodies (MDAs) impair piglets' humoral and cellular immune responses to vaccination against porcine reproductive and respiratory syndrome (PRRS).
Q93085100Maternally-derived neutralizing antibodies reduce vaccine efficacy against porcine reproductive and respiratory syndrome virus infection
Q98726777Modelling infectious viral diseases in swine populations: a state of the art
Q54406243Modified-live PRRSV subtype 1 vaccine UNISTRAIN® PRRS provides a partial clinical and virological protection upon challenge with East European subtype 3 PRRSV strain Lena.
Q89981737New insights about vaccine effectiveness: Impact of attenuated PRRS-strain vaccination on heterologous strain transmission
Q40190399Oral fluid versus blood sampling in group-housed sows and finishing pigs: Feasibility and performance of antibody detection for porcine reproductive and respiratory syndrome virus (PRRSV).
Q94660740PCV2 co-infection does not impact PRRSV MLV1 safety but enhances virulence of a PRRSV MLV1-like strain in infected SPF pigs
Q90064898Pathogen transmission from vaccinated hosts can cause dose-dependent reduction in virulence
Q93011930Predicting vaccine effectiveness in livestock populations: A theoretical framework applied to PRRS virus infections in pigs
Q40190413Preparation for emergence of an Eastern European porcine reproductive and respiratory syndrome virus (PRRSV) strain in Western Europe: Immunization with modified live virus vaccines or a field strain confers partial protection
Q28071014Review on the transmission porcine reproductive and respiratory syndrome virus between pigs and farms and impact on vaccination
Q40520410Strategies to broaden the cross-protective efficacy of vaccines against porcine reproductive and respiratory syndrome virus.
Q53505792The use of vaccines to control pathogen spread in pig populations.
Q40296647Transmission of Porcine reproductive and respiratory syndrome virus 1 to and from vaccinated pigs in a one-to-one model.

Search more.